Literature DB >> 15924299

Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease.

Maria Martinez1, Alexis Brice, Jenny R Vaughan, Alexander Zimprich, Monique M B Breteler, Giuseppe Meco, Alessandro Filla, Matthew J Farrer, Christine Bétard, Andrew Singleton, John Hardy, Giuseppe De Michele, Vincenzo Bonifati, Ben A Oostra, Thomas Gasser, Nick W Wood, Alexandra Dürr.   

Abstract

Analysis of the apolipoprotein E genotype in sibpairs with Parkinson's disease showed the E4 allele was over represented in those who shared the adjacent chromosome 19 markers. This suggests that apolipoprotein E4 is responsible for the linkage peak in this region and that it is a modest risk factor for Parkinson's disease. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924299     DOI: 10.1002/ajmg.b.30196

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  13 in total

1.  APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

2.  A large study reveals no association between APOE and Parkinson's disease.

Authors:  Monica Federoff; Belen Jimenez-Rolando; Michael A Nalls; Andrew B Singleton
Journal:  Neurobiol Dis       Date:  2012-02-12       Impact factor: 5.996

Review 3.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

Review 4.  Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  J Med Chem       Date:  2012-10-05       Impact factor: 7.446

5.  Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.

Authors:  Stephen Arold; Patrick Sullivan; Tina Bilousova; Edmond Teng; Carol A Miller; Wayne W Poon; Harry V Vinters; Lindsey B Cornwell; Tommy Saing; Gregory M Cole; Karen Hoppens Gylys
Journal:  Acta Neuropathol       Date:  2011-10-22       Impact factor: 17.088

Review 6.  Apolipoprotein e sets the stage: response to injury triggers neuropathology.

Authors:  Robert W Mahley; Yadong Huang
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

Review 7.  Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.

Authors:  Yadong Huang; Robert W Mahley
Journal:  Neurobiol Dis       Date:  2014-08-27       Impact factor: 5.996

Review 8.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

Review 9.  The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease.

Authors:  Dilek Inekci; Ditte Svendsen Jonesco; Sophie Kennard; Morten Asser Karsdal; Kim Henriksen
Journal:  Front Neurol       Date:  2015-05-11       Impact factor: 4.003

Review 10.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Authors:  Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.